Company profile
Johnson & Johnson
Pipeline16 assets
- guselkumabTREMFYA / IL-23 / Monoclonal Antibody / ImmunologyPsoriasisPsoriatic ArthritisCrohn's Disease
- ibrutinibIMBRUVICA / BTK / Small Molecule / OncologyMantle Cell LymphomaOther B-cell malignancies
- icotrokinraJNJ-2113 / IL-23R / Targeted Oral Peptide / ImmunologyPsoriasisPsoriatic Arthritis
- JNJ-4804JNJ-4804 / Co-antibody / Co-antibody Therapy / ImmunologyUlcerative Colitis
- nipocalimabIMAAVY / FcRn / Monoclonal Antibody / Immunology / NeuroscienceGeneralized Myasthenia GravisRheumatoid ArthritisWarm Autoimmune Hemolytic Anemia
- aticaprantKOR antagonist / Small Molecule / NeuroscienceAdjunctive Treatment for Major Depressive Disorder with Anhedonia
- RPGR Gene TherapyRPGR / Gene Therapy / Vision / OphthalmologyRetinitis Pigmentosa
- teclistamabTECVAYLI / BCMA x CD3 / Bispecific Antibody / OncologyMultiple Myeloma
- sCD59JNJ-1887 / sCD59 / Gene Therapy / Vision / OphthalmologyGeographic Atrophy
- gemcitabine intravesical delivery systemTAR-200 / INLEXZO / DNA synthesis / Drug Delivery System / OncologyHigh Risk Non-Muscle Invasive Bladder Cancer
- niraparib / abirateroneAKEEGA / PARP / CYP17 / Small Molecule Combination / OncologyMetastatic Castration-Sensitive Prostate CancerMetastatic Castration-Resistant Prostate Cancer
- daratumumabDARZALEX / CD38 / Monoclonal Antibody / OncologyMultiple Myeloma
- erdafitinibBALVERSA / FGFR / Small Molecule / OncologyUrothelial Carcinoma
- apalutamideERLEADA / Androgen Receptor / Small Molecule / OncologyProstate Cancer
- ciltacabtagene autoleucelCARVYKTI / BCMA / CAR-T Cell Therapy / OncologyMultiple Myeloma
- Filovirus multivalent vaccineVAC69120 / MVA-BN-Filo / Ebola Virus / Vaccine / Infectious DiseasesEbola